Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer

British Journal of Cancer

Volumn 89, Issue 11, 2003, Pages 2116-2121

  Tanioka, Y ^a   Yoshida, T ^a   Yagawa, T ^a   Saiki, Y ^a   Takeo, S ^a   Harada, T ^a   Okazawa, T ^a   Yanai, H ^a   Okita, K ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Lymph node metastasis; Matrix metalloproteinase 7; Matrix metalloproteinase 9; Prognostic factor; Superficial oesophageal cancer

Indexed keywords

GELATINASE B; MATRILYSIN; TUMOR MARKER;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ESOPHAGUS CANCER; FEMALE; HEALTH CARE POLICY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; RISK FACTOR; SUPERFICIAL CANCER;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 7; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 0346788917     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601372     Document Type: Article

References (33)

1. Adachi Y, Itoh F, Yamamoto H, Matsuno K, Arimura Y, Kusano M, Endoh T, Hinoda Y, Oohara M, Hosokawa M, Imai K (1998) Matrix metalloproteinase matrilysin (MMP-7) participates in the progression of human gastric and esophageal cancers. Int J Oncol 13: 1031-1035
2. Adachi Y, Yamamoto H, Itoh F, Arimura Y, Nishi M, Endo T, Imai K (2001) Clinicopathologic and prognostic significance of matrilysin expression at the invasive front in human colorectal cancers. Int J Cancer (Pred Oncol) 95: 290-294
3. Baker EA, Leaper DJ (2002) Measuring gelatinase activity in colorectal cancer. Eur J Surg Oncol 28: 24-29
4. Baragi VM, Fliszar CJ, Conroy MC, Ye Q, Shipley JM, Welgus HG (1994) Contribution of the c-terminal domain of metalloproteinases to binding by tissue inhibitor of metalloproteinases. J Biol Chem 269: 12692-12697
5. Bogomoletz WV, Molas G, Gayet B, Potet F (1989) Superficial squamous cell carcinoma of the esophagus: a report of 76 cases and review of the literature. Am J Surg Pathol 13: 535-546
6. Brodmerkel Jr GJ (1971) Schiller's test: an aid in esophagoscopic diagnosis. Gastroenterol 60: 813
7. Endo M, Takeshita K, Yoshida M (1986) How can we diagnose the early stage of esophageal cancer? Endoscopy 18: 11-18
8. Japanese Society for esophageal Disease (2001) Guidelines for clinical and pathologic studies on carcinoma of the esophagus, Ninth ed. Tokyo: Kanehara & Co., Ltd
9. Kato Y, Yamashita T, Ishikawa M (2002) Relationship between expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 and invasion ability of cervical cancer cells. Oncol Rep 9: 565-569
10. Kawano N, Osawa H, Ito K, Nagashima Y, Hirahara F, Inayama Y, Nakatani Y, Kimura S, Kitajima H, Koshikawa N, Miyazaki K, Kitamura H (1997) Expression of gelatinase A, tissue inhibitor of metalloproteinase-2, matrilysin, and trypsin(ogen) in lung neoplasms: an immunohistochemical study. Human Pathol 28: 613-622
11. Kodama M, Kakegawa T (1998) Treatment of superficial cancer of the esophagus: a summary of responses to a questionnaire on superficial cancer of the esophagus in Japan. Surgery 123: 432-439
12. Koyama H, Iwata H, Kuwabara Y, Iwase H, Kobayashi S, Fujii Y (2000) Gelatinolytic activity of matrix metalloproteinase-2 and -9 in esophageal carcinoma; a study using in situ zymography. Eur J Cancer 36: 2164-2170
13. Krevsky B. Tumors of the esophagus. In: Haubrich WS, Schaffner F, Berk JE (eds) (1995) Bockus Gastroenterology, Fifth ed. Philadelphia: W.B. Saunders Company pp 534-557
14. Liu XP, Kawauchi S, Oga A, Tsushimi K, Furuya T, Sasaki K (2002) Prognostic significance of matrix metalloproteinase-7 (MMP-7) expression at the invasive front in gastric carcinoma. Jpn J Cancer Res 93: 291-295
15. Matrisian LM (1992) The matrix-degrading metalloproteinases. BioEssays 14: 455-463
16. McDonnell S, Navre M, Coffey Jr RJ, Matrisian LM (1991) Expression and localization of matrix metalloproteinase pump-1 (MMP-7) in human gastric and colon carcinomas. Molecular Carcinogenesis 4: 527-533
17. Medical Research Council Oesophageal Cancer Working Party (2002) Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 359: 1727-1733
18. Miyazaki K, Hattori Y, Umenishi F, Yasumitsu H, Umeda M (1990) Purification and characterization of extracellular matrix-degrading metalloproteinase, matrin (pump-1), secreted from human rectal carcinoma cell line. Cancer Res 50: 7758-7764
19. Murray GI, Duncan ME, O'Neil P, McKay JA, Melvin WT, Fothergill JE (1998) Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer. J Pathol 185: 256-261
20. Nagakawa Y, Aoki T, Kasuya K, Tsuchida A, Koyanagi Y (2002) Histologic features of venous invasion, expression of vascular endothelial growth factor and matrix metalloproteinase-2 and matrix metalloproteinase-9, and the relation with liver metastasis in pancreatic cancer. Pancreas 24: 169-178
21. Ohashi K, Nemoto T, Nakamura K, Nemori R (2000) Increased expression of matrix metalloproteinase 7 and 9 and membrane type 1-matrix metalloproteinase in esophageal squamous cell carcinomas. Cancer 88: 2201-2209
22. Parsons SL, Watson SA, Brown PD, Collins HM, Steele RJC (1997) Matrix metalloproteinases. Br J Surg 84: 160-166
23. Sato F, Shimada Y, Watanabe G, Uchida S, Makino T, Imamura M (1999) Expression of vascular endothelial growth factor, matrix metalloproteinase-9 and E-cadherin in the process of lymph node metastasis in oesophageal cancer. Br J Cancer 80: 1366-1372
24. Takeo Y, Yoshida T, Shigemitsu T, Yanai H, Hayashi N, Okita K (2001) Endoscopic mucosal resection for early esophageal cancer and oesophageal dysplasia. Hepatogastroenterology 48: 453-457
25. Torii A, Kodera Y, Ito M, Shimizu Y, Hirai T, Yasui K, Morimoto T, Yamamura Y, Kato T, Hayakawa T, Fujimoto N, Kito T (1998) Matrix metalloproteinase 9 in mucosally invasive gastric cancer. Gastric Cancer 1: 142-145
26. Wilson CL, Heppner KJ, Labosky PA, Hogan BL, Matrisian LM (1997) Intestinal tumourigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc Natl Acad Sci USA 94: 1402-1407
27. Yamamoto H, Adachi Y, Itoh F, Iku S, Matsuno K, Kusano M, Arimura Y, Endo T, Hinoda Y, Hosokawa M, Imai K (1999) Association of matrilysin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma. Cancer Res 59: 3313-3316
28. Yamamoto H, Itoh F, Adachi Y, Sakamoto H, Adachi M, Hinoda Y, Imai K (1997) Relation of enhanced secretion of active matrix metalloproteinases with tumor spread in human hepatocellular carcinoma. Gastroenterol 112: 1290-1296
29. Yamashita K, Azumano I, Mai M, Okada Y (1998) Expression and tissue localization of matrix metalloproteinase-7 (matrilysin) in human gastric carcinomas. Implications for vessel invasion and metastasis. Int J Cancer (Pred Oncol) 79: 187-194
30. Yamashita K, Mori M, Shiraishi T, Shibuta K, Sugimachi K (2000) Clinical significance of matrix metalloproteinase-7 expression in esophageal carcinoma. Clin Cancer Res 6: 1169-1174
31. Yanai H, Harada T, Matsumoto Y, Yoshida T, Tada M, Okita K (1997) Invitro endosonographic appearance of muscularis mucosae of the esophagus. Endoscopy 29: S49
32. Yanai H, Yoshida T, Harada T, Matsumoto Y, Nishiaki M, Shigemitsu T, Tada M, Okita K, Kawano T, Nagasaki S (1996) Endoscopic ultrasonography of superficial esophageal cancers using a thin ultrasound probe system equipped with switchable radial and linear scanning modes. Gastrointest Endosc 44: 578-582
33. Yoshimoto M, Itoh F, Yamamoto H, Hinoda Y, Imai K, Yachi A (1993) Expression of MMP-7 (pump-1) mRNA in human colorectal cancers. Int J Cancer 54: 614-618